Onur Eroglu

1PUBLICATIONS
1CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 04, 2022
Combined treatment with ruxolitinib and MK-2206 inhibits the JAK2/STAT5 and PI3K/AKT pathways via apoptosis in MDA-MB-231 breast cancer cell line.

Esin Guvenir Celik, Onur Eroglu

Pageof 1

Frequent Collaborators

1 joint publications

Esin Guvenir Celik